The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

[1]  Joseph Avruch,et al.  Faculty Opinions recommendation of mTOR kinase structure, mechanism and regulation. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  Marco J. Morelli,et al.  Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc , 2016, Oncotarget.

[3]  M. V. Giuli,et al.  Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression , 2016, Oncogene.

[4]  M. Yamaguchi,et al.  Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype , 2016, Laboratory Investigation.

[5]  H. Yun,et al.  Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression , 2015, British journal of pharmacology.

[6]  G. Del Sal,et al.  Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships. , 2015, Biochimica et biophysica acta.

[7]  S. Romano,et al.  Pleiotropic roles in cancer biology for multifaceted proteins FKBPs. , 2015, Biochimica et biophysica acta.

[8]  Xiao Zhen Zhou,et al.  Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease. , 2015, Biochimica et biophysica acta.

[9]  A. Ellington,et al.  Chemical Tools To Decipher Regulation of Phosphatases by Proline Isomerization on Eukaryotic RNA Polymerase II. , 2015, ACS chemical biology.

[10]  Ann C. McKee,et al.  Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy , 2015, Nature.

[11]  Sung-Chul Lim,et al.  COT phosphorylates prolyl‐isomerase Pin1 to promote tumorigenesis in breast cancer , 2015, Molecular carcinogenesis.

[12]  B. Novák,et al.  Human chromosome segregation involves multi-layered regulation of separase by the peptidyl-prolyl-isomerase Pin1. , 2015, Molecular cell.

[13]  Christopher L. Warren,et al.  Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α* , 2015, The Journal of Biological Chemistry.

[14]  P. Pandolfi,et al.  Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer , 2015, Nature Medicine.

[15]  J. Lieberman,et al.  The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation , 2015, Cell reports.

[16]  A. Jo,et al.  Prolyl isomerase PIN1 negatively regulates SGK1 stability to mediate tamoxifen resistance in breast cancer cells. , 2015, Anticancer research.

[17]  Y. Tong,et al.  Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage , 2015, Cell Death and Disease.

[18]  M. Tang,et al.  SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. , 2014, Cancer research.

[19]  Jeremy D. DeBarry,et al.  Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation , 2014, Nature.

[20]  M. Hsiao,et al.  MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1. , 2014, Biochimica et biophysica acta.

[21]  N. Navin.  Cancer genomics: one cell at a time , 2014, Genome Biology.

[22]  T. Hunter,et al.  Prolyl isomerase Pin1 in cancer , 2014, Cell Research.

[23]  Mark A Sussman,et al.  Pin1: a molecular orchestrator in the heart. , 2014, Trends in cardiovascular medicine.

[24]  J. Lieberman,et al.  Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. , 2014, Cancer research.

[25]  Sung-Chul Lim,et al.  Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation. , 2014, Carcinogenesis.

[26]  H. Kantarjian,et al.  Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data. , 2014, Clinical lymphoma, myeloma & leukemia.

[27]  A. Ryo,et al.  Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors , 2014, Oncogene.

[28]  S. Bicciato,et al.  Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast , 2013, EMBO molecular medicine.

[29]  Yu-Chyi Hwang,et al.  Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association. , 2013, Biochimica et biophysica acta.

[30]  Z. Xiao,et al.  Pin1 modulates p63α protein stability in regulation of cell survival, proliferation and tumor formation , 2013, Cell Death and Disease.

[31]  Chi-Ying F. Huang,et al.  Pin1 acts as a negative regulator of the G2/M transition by interacting with the Aurora-A–Bora complex , 2013, Journal of Cell Science.

[32]  Jonathan C. Guito,et al.  The Cellular Peptidyl-Prolyl cis/trans Isomerase Pin1 Regulates Reactivation of Kaposi's Sarcoma-Associated Herpesvirus from Latency , 2013, Journal of Virology.

[33]  P. Khanal,et al.  The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells , 2013, Molecular carcinogenesis.

[34]  Zhihua Liu,et al.  Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis* , 2013, The Journal of Biological Chemistry.

[35]  D. Litchfield,et al.  Mitotic Regulation of SEPT9 Protein by Cyclin-dependent Kinase 1 (Cdk1) and Pin1 Protein Is Important for the Completion of Cytokinesis* , 2013, The Journal of Biological Chemistry.

[36]  Sung-Chul Lim,et al.  Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  Andrew Potter,et al.  Pin1 inhibitors: Pitfalls, progress and cellular pharmacology. , 2013, Bioorganic & medicinal chemistry letters.

[38]  J. Skotheim,et al.  Control of cell cycle transcription during G1 and S phases , 2013, Nature Reviews Molecular Cell Biology.

[39]  Yun Lin,et al.  The rs2233678 Polymorphism in PIN1 Promoter Region Reduced Cancer Risk: A Meta-Analysis , 2013, PloS one.

[40]  H. Shih,et al.  SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. , 2013, Cancer research.

[41]  B. Gerrits,et al.  Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection. , 2013, Molecular cell.

[42]  Colin J. Daniel,et al.  Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis , 2013, Molecular and Cellular Biology.

[43]  H. de Thé,et al.  Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies , 2013, The Journal of experimental medicine.

[44]  S. Sukumar,et al.  Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment , 2013, Clinical Cancer Research.

[45]  K. Aldape,et al.  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect , 2012, Nature Cell Biology.

[46]  Erik van der Wal,et al.  Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability. , 2012, Biochimica et biophysica acta.

[47]  A. Giordano,et al.  Androgen receptor serine 81 mediates Pin1 interaction and activity , 2012, Cell cycle.

[48]  H. de Thé,et al.  Acute promyelocytic leukemia, arsenic, and PML bodies , 2012, The Journal of cell biology.

[49]  J. Decaprio,et al.  Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. , 2012, Molecular cell.

[50]  Y. Liou,et al.  Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis , 2012, Oncogene.

[51]  Akihide Ryo,et al.  Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin , 2012, Molecular and Cellular Biology.

[52]  M. Salto‐Tellez,et al.  Prolyl isomerase Pin1 down-regulates tumor suppressor RUNX3 in breast cancer , 2012, Oncogene.

[53]  K. Lu,et al.  Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function , 2012, Proceedings of the National Academy of Sciences.

[54]  Yong-Yeon Cho,et al.  TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2 , 2012, Molecular and Cellular Biochemistry.

[55]  K. Lu,et al.  A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease , 2012, Neurobiology of Aging.

[56]  L. Nicholson,et al.  Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease , 2012, Cell.

[57]  Sudha Seshadri,et al.  Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study , 2012, BMJ : British Medical Journal.

[58]  A. Klein-Szanto,et al.  Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 , 2012, Cell Death and Differentiation.

[59]  Jae K. Lee,et al.  Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy. , 2011, Neoplasia.

[60]  S. Haslam,et al.  Regulation of Estrogen Receptor (cid:1) N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1 , 2022 .

[61]  W. Rathmell,et al.  Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma , 2011, Molecular oncology.

[62]  Y. Liou,et al.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. , 2011, Trends in biochemical sciences.

[63]  Weiwei Yang,et al.  Ras-Induced and Extracellular Signal-Regulated Kinase 1 and 2 Phosphorylation-Dependent Isomerization of Protein Tyrosine Phosphatase (PTP)-PEST by PIN1 Promotes FAK Dephosphorylation by PTP-PEST , 2011, Molecular and Cellular Biology.

[64]  S. Obchoei,et al.  Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma , 2011, Molecular Cancer.

[65]  Yu‐Min Lin,et al.  A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression. , 2011, Cancer Cell.

[66]  G. Fischer,et al.  Prolyl cis/trans isomerase signalling pathways in cancer. , 2011, Current opinion in pharmacology.

[67]  A. Bode,et al.  Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1 , 2011, Cancer Prevention Research.

[68]  Antonio Rosato,et al.  A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. , 2011, Cancer cell.

[69]  E. Israel,et al.  Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity , 2011, Nature Immunology.

[70]  C. Uchida,et al.  A critical step for JNK activation: isomerization by the prolyl isomerase Pin1 , 2011, Cell Death and Differentiation.

[71]  A. Goate,et al.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. , 2011, Molecular cell.

[72]  Hidenori Akutsu,et al.  A Distinct Role for Pin1 in the Induction and Maintenance of Pluripotency* , 2011, The Journal of Biological Chemistry.

[73]  B. Davis,et al.  Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. , 2011, Bioorganic & medicinal chemistry letters.

[74]  Zhu Chen,et al.  Acute promyelocytic leukaemia: novel insights into the mechanisms of cure , 2010, Nature Reviews Cancer.

[75]  F. Guillemot,et al.  Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1 , 2010, Proceedings of the National Academy of Sciences.

[76]  K. Hochedlinger,et al.  Induced pluripotency: history, mechanisms, and applications. , 2010, Genes & development.

[77]  O. Arrieta,et al.  Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  S. Briggs,et al.  Phosphorylation stabilizes Nanog by promoting its interaction with Pin1 , 2010, Proceedings of the National Academy of Sciences.

[79]  Young-hoon Han,et al.  The cleavage fragment of retinoid X receptor-alpha ligand binding domain inhibits radiosensitization by retinoic acid. , 2010, Oncology reports.

[80]  S. Bohlander,et al.  Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML , 2010, Leukemia.

[81]  W. J. Choi,et al.  Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells. , 2010, Oncology reports.

[82]  D. Pei,et al.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1. , 2010, Journal of medicinal chemistry.

[83]  P. Khanal,et al.  The Prolyl Isomerase Pin1 Enhances HER-2 Expression and Cellular Transformation via Its Interaction with Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase 1 , 2010, Molecular Cancer Therapeutics.

[84]  Zhaoli Chen,et al.  Pin1 expression contributes to lung cancer prognosis and carcinogenesis , 2010, Cancer biology & therapy.

[85]  B. Davis,et al.  Structure-guided design of alpha-amino acid-derived Pin1 inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[86]  W. Shou,et al.  FKBP51 and Cyp40 are Positive Regulators of Androgen-dependent Prostate Cancer Cell Growth and the Targets of FK506 and Cyclosporin A , 2009, Oncogene.

[87]  Li-E. Wang,et al.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. , 2009, Carcinogenesis.

[88]  Samantha Greasley,et al.  Structure-based design of novel human Pin1 inhibitors (I). , 2009, Bioorganic & medicinal chemistry letters.

[89]  F. Etzkorn,et al.  Pin1 as an anticancer drug target. , 2009, Drug news & perspectives.

[90]  K. Khanna,et al.  The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55. , 2009, Cancer research.

[91]  M. Cazzaniga,et al.  Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[93]  K. Aldape,et al.  FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. , 2009, Molecular cell.

[94]  X. Zhou,et al.  Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation , 2009, Oncogene.

[95]  A. Ryo,et al.  The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation. , 2009, Biochemical and biophysical research communications.

[96]  Z. Dong,et al.  The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. , 2009, Carcinogenesis.

[97]  K. Miyazono,et al.  Pin1 Down-regulates Transforming Growth Factor-β (TGF-β) Signaling by Inducing Degradation of Smad Proteins* , 2009, Journal of Biological Chemistry.

[98]  Pier Paolo Di Fiore,et al.  The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer , 2009, Nature Cell Biology.

[99]  K. Jeang,et al.  Peptidylproline cis-trans-Isomerase Pin1 Interacts with Human T-Cell Leukemia Virus Type 1 Tax and Modulates Its Activation of NF-κB , 2009, Journal of Virology.

[100]  K. Lu,et al.  Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability , 2008, Molecular Cancer.

[101]  P. Pandolfi,et al.  Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation , 2008, Nature Medicine.

[102]  Hung-Ying Kao,et al.  Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT , 2008, The Journal of cell biology.

[103]  J. Koblinski,et al.  Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. , 2008, Cancer research.

[104]  P. V. van Diest,et al.  The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. , 2008, Cancer research.

[105]  A. McCulloch,et al.  Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. , 2008, The Journal of clinical investigation.

[106]  Y. Liou,et al.  Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy. , 2008, The Journal of clinical investigation.

[107]  R. Ramlau,et al.  Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  Zhen-yi Wang,et al.  Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.

[109]  J. Engelman,et al.  Acquired resistance to tyrosine kinase inhibitors during cancer therapy. , 2008, Current opinion in genetics & development.

[110]  T. Uchida,et al.  Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity , 2007, Oncogene.

[111]  Kristopher J. Stanya,et al.  Degradation of the Tumor Suppressor PML by Pin1 Contributes to the Cancer Phenotype of Breast Cancer MDA-MB-231 Cells , 2007, Molecular and Cellular Biology.

[112]  J. Manley,et al.  Pin1 modulates RNA polymerase II activity during the transcription cycle. , 2007, Genes & development.

[113]  Xiao Zhen Zhou,et al.  The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease , 2007, Nature Reviews Molecular Cell Biology.

[114]  N. Moore,et al.  Steroid receptor phosphorylation: a key modulator of multiple receptor functions. , 2007, Molecular endocrinology.

[115]  L. Nicholson,et al.  Prolyl cis-trans isomerization as a molecular timer. , 2007, Nature chemical biology.

[116]  Xin Lu,et al.  The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP , 2007, Nature Structural &Molecular Biology.

[117]  James E. Ferrell,et al.  Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.

[118]  A. Rao,et al.  Linking calcineurin activity to leukemogenesis , 2007, Nature Medicine.

[119]  H. Akiyama,et al.  Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1 , 2007, Oncogene.

[120]  M. Bowman,et al.  Structural basis for high-affinity peptide inhibition of human Pin1. , 2007, ACS chemical biology.

[121]  Elisabeth S Yeh,et al.  PIN1, the cell cycle and cancer , 2007, Nature Reviews Cancer.

[122]  J. Manley,et al.  The prolyl isomerase Pin1 functions in mitotic chromosome condensation. , 2007, Molecular cell.

[123]  L. Nicholson,et al.  The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production , 2007, Nature.

[124]  N. Sagata,et al.  Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase , 2007, Proceedings of the National Academy of Sciences.

[125]  Y. Kwong,et al.  Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. , 2007, Gastroenterology.

[126]  G. Annoni,et al.  PIN1 promoter polymorphisms are associated with Alzheimer's disease , 2007, Neurobiology of Aging.

[127]  J. Labbé,et al.  Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCFβtrcp , 2007, EMBO reports.

[128]  Y. Kwong,et al.  PIN1 expression contributes to hepatic carcinogenesis , 2006, The Journal of pathology.

[129]  S. Reed,et al.  Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. , 2006, Molecular cell.

[130]  A. Kimchi,et al.  The death-associated protein kinases: structure, function, and beyond. , 2006, Annual review of biochemistry.

[131]  A. Delacourte,et al.  Pin1 allows for differential Tau dephosphorylation in neuronal cells , 2006, Molecular and Cellular Neuroscience.

[132]  J. Tyler,et al.  Transcriptional Activators Are Dispensable for Transcription in the Absence of Spt6-Mediated Chromatin Reassembly of Promoter Regions (DOI: 10.1016/j.molcel.2005.12.010) , 2006 .

[133]  Xiao Zhen Zhou,et al.  Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. , 2006, Journal of medicinal chemistry.

[134]  A. Ryo,et al.  Pin1 Regulates Centrosome Duplication, and Its Overexpression Induces Centrosome Amplification, Chromosome Instability, and Oncogenesis , 2006, Molecular and Cellular Biology.

[135]  K. Saxena,et al.  Polo-like Kinase 1-mediated Phosphorylation Stabilizes Pin1 by Inhibiting Its Ubiquitination in Human Cells* , 2005, Journal of Biological Chemistry.

[136]  A. Means,et al.  Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1) , 2005, Molecular and Cellular Biology.

[137]  J. Gutkind,et al.  Regulation of the Transcriptional Activity of c-Fos by ERK , 2005, Journal of Biological Chemistry.

[138]  T. Pawson,et al.  Protein phosphorylation in signaling--50 years and counting. , 2005, Trends in biochemical sciences.

[139]  K. Lu,et al.  Phosphorylation-specific prolyl isomerization: is there an underlying theme? , 2005, Nature Cell Biology.

[140]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[141]  T. Klimkait,et al.  The peptidyl–prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor α stability , 2005 .

[142]  Ming Zhou,et al.  Regulation of Raf-1 by direct feedback phosphorylation. , 2005, Molecular cell.

[143]  K. Strebhardt,et al.  Polo-like kinases and oncogenesis , 2005, Oncogene.

[144]  Bailing Xu,et al.  Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. , 2004, Journal of the American Chemical Society.

[145]  Priti Garg,et al.  Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis , 2004, The EMBO journal.

[146]  A. Means,et al.  PINA Is Essential for Growth and Positively Influences NIMA Function in Aspergillus nidulans* , 2004, Journal of Biological Chemistry.

[147]  J. Sowadski,et al.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers. , 2004, The American journal of pathology.

[148]  K. Lu.  Pinning down cell signaling, cancer and Alzheimer's disease. , 2004, Trends in biochemical sciences.

[149]  Joseph R. Nevins,et al.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.

[150]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[151]  A. Means,et al.  Spermatogonial Depletion in Adult Pin1-Deficient Mice1 , 2003, Biology of reproduction.

[152]  K. Shokat,et al.  Targets of the cyclin-dependent kinase Cdk1 , 2003, Nature.

[153]  Anna Frolov,et al.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. , 2003, Cancer research.

[154]  K. Lu.  Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. , 2003, Cancer cell.

[155]  A. Means,et al.  Pin1 regulates the timing of mammalian primordial germ cell proliferation , 2003, Development.

[156]  Tony Hunter,et al.  Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.

[157]  D. Barford,et al.  The structure of the cell cycle protein Cdc14 reveals a proline‐directed protein phosphatase , 2003, The EMBO journal.

[158]  Sam W. Lee,et al.  Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and Cell Cycle Checkpoints in Response to DNA Damage* , 2002, The Journal of Biological Chemistry.

[159]  S. Murray,et al.  The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response , 2002, Nature.

[160]  S. Volinia,et al.  The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults , 2002, Nature.

[161]  Sam W. Lee,et al.  PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.

[162]  Y. Liou,et al.  Pinning down proline-directed phosphorylation signaling. , 2002, Trends in cell biology.

[163]  Xiao Zhen Zhou,et al.  Pin1 modulates the dephosphorylation of the RNA polymerase II C‐terminal domain by yeast Fcp1 , 2002, FEBS letters.

[164]  J. Noel,et al.  Critical Role of WW Domain Phosphorylation in Regulating Phosphoserine Binding Activity and Pin1 Function* , 2002, The Journal of Biological Chemistry.

[165]  T. Hunter,et al.  Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[166]  Tianhua Niu,et al.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.

[167]  M. Kirschner,et al.  Pin1 acts catalytically to promote a conformational change in Cdc25. , 2001, Molecular cell.

[168]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[169]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[170]  L. Nicholson,et al.  Phosphorylation-induced structural changes in the amyloid precursor protein cytoplasmic tail detected by NMR. , 2001, Journal of molecular biology.

[171]  A. Greenleaf,et al.  Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. , 2001, Nucleic acids research.

[172]  G Fischer,et al.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. , 2000, Molecular cell.

[173]  T. Grunt,et al.  Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. , 2000, Cancer research.

[174]  M. Schutkowski,et al.  Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase , 2000, FEBS letters.

[175]  W. El-Deiry,et al.  BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression* , 2000, The Journal of Biological Chemistry.

[176]  K. Lu,et al.  Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism , 1999, Cellular and Molecular Life Sciences CMLS.

[177]  C. Uchida,et al.  Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. , 1999, Biochemical and biophysical research communications.

[178]  L. Johnson,et al.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.

[179]  R. Gartenhaus,et al.  Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[180]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[181]  Xiao Zhen Zhou,et al.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules. , 1999, Science.

[182]  John Calvin Reed,et al.  A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. , 1998, British Journal of Cancer.

[183]  G. Fischer,et al.  Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. , 1998, Biochemistry.

[184]  M. Kirschner,et al.  The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. , 1998, Genes & development.

[185]  P. Adamson,et al.  Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[186]  M. Kirschner,et al.  Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. , 1997, Science.

[187]  R. Ranganathan,et al.  Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent , 1997, Cell.

[188]  T. Hunter,et al.  A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.

[189]  G. Opelz,et al.  Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation , 1995, The Lancet.

[190]  E. Dmitrovsky,et al.  Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. , 1992, Blood.

[191]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[192]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[193]  Xiao Zhen Zhou,et al.  ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1. , 2016, Molecular cell.

[194]  M. Buendia,et al.  Hepatocellular carcinoma. , 2015, Cold Spring Harbor perspectives in medicine.

[195]  김병모.  Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease , 2015 .

[196]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[197]  J. Thomson,et al.  Structure-based design of novel human Pin1 inhibitors (II). , 2010, Bioorganic & medicinal chemistry letters.

[198]  Xiao Zhen Zhou,et al.  Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance , 2009, Nature Cell Biology.

[199]  中野 綾子.  Pin1 downregulates TGF-β signaling by inducing degradation of Smad proteins , 2009 .

[200]  S. Elledge,et al.  Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.

[201]  R. Arceci.  PML targeting eradicates quiescent leukaemia-initiating cells , 2009 .

[202]  R. Minchin,et al.  Peptidyl Prolyl Cis-Trans Isomerase Pin1 , 2009 .

[203]  T. Klimkait,et al.  The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability. , 2005, Biochemical and biophysical research communications.

[204]  Y. Matsuo,et al.  Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. , 2003, Chemistry & biology.

[205]  Xiao Zhen Zhou,et al.  Pin 1 modulates the dephosphorylation of the RNA polymerase II C-terminal domain by yeast Fcp 1 , 2002 .

[206]  Masafumi Nakamura,et al.  Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC , 2001, Nature Cell Biology.

[207]  D O Morgan,et al.  Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.